Literature DB >> 16819576

The nerve-heart connection in the pro-oxidant response to Mg-deficiency.

Maria Isabel Tejero-Taldo1, Jay Harlan Kramer, Iu Tong Mak, Andrei M Komarov, William Bernard Weglicki.   

Abstract

Magnesium is a micronutrient essential for the normal functioning of the cardiovascular system, and Mg deficiency (MgD) is frequently associated in the clinical setting with chronic pathologies such as CHF, diabetes, hypertension, and other pathologies. Animal models of MgD have demonstrated a systemic pro-inflammatory/pro-oxidant state, involving multiple tissues/organs including neuronal, hematopoietic, cardiovascular, and gastrointestinal systems; during later stages of MgD, a cardiomyopathy develops which may result from a cascade of inflammatory events. In rodent models of dietary MgD, a significant rise in circulating levels of proinflammatory neuropeptides such as substance P (SP) and calcitonin gene-related peptide among others, was observed within days (1-7) of initiating the Mg-restricted diet, and implicated a neurogenic trigger for the subsequent inflammatory events; this early "neurogenic inflammation" phase may be mediated in part, by the Mg-gated N: -methyl-D-aspartate (NMDA) receptor/channel complex. Deregulation of the NMDA receptor may trigger the abrupt release of neuronal SP from the sensory-motor C-fibers to promote the subsequent pro-inflammatory changes: elevations in circulating inflammatory cells, inflammatory cytokines, histamine, and PGE(2) levels, as well as formation of nitric oxide, reactive oxygen species, lipid peroxidation products, and depletion of key endogenous antioxidants. Concurrent elevations of tissue CD14, a high affinity receptor for lipopolyssacharide, suggest that intestinal permeability may be compromised leading to endotoxemia. If exposure to these early (1-3 weeks MgD) inflammatory/pro-oxidant events becomes prolonged, this might lead to impaired cardiac function, and when co-existing with other pathologies, may enhance the risk of developing chronic heart failure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16819576     DOI: 10.1007/s10741-006-9191-7

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.654


  85 in total

1.  Cytokines, neuropeptides, and reperfusion injury during magnesium deficiency.

Authors:  W B Weglicki; T M Phillips; I T Mak; M M Cassidy; B F Dickens; R Stafford; J H Kramer
Journal:  Ann N Y Acad Sci       Date:  1994-06-17       Impact factor: 5.691

2.  Mild hypothermia and Mg++ protect against irreversible damage during CNS ischemia.

Authors:  F X Vacanti; A Ames
Journal:  Stroke       Date:  1984 Jul-Aug       Impact factor: 7.914

3.  Activation of the neutrophil and loss of plasma glutathione during Mg-deficiency--modulation by nitric oxide synthase inhibition.

Authors:  I T Mak; B F Dickens; A M Komarov; T L Wagner; T M Phillips; W B Weglicki
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

4.  Enhanced tumor necrosis factor-alpha production following endotoxin challenge in rats is an early event during magnesium deficiency.

Authors:  C Malpuech-Brugère; W Nowacki; E Rock; E Gueux; A Mazur; Y Rayssiguier
Journal:  Biochim Biophys Acta       Date:  1999-01-06

5.  Role of magnesium in glutathione metabolism of rat erythrocytes.

Authors:  J M Hsu; B Rubenstein; A G Paleker
Journal:  J Nutr       Date:  1982-03       Impact factor: 4.798

6.  Magnesium and cobalt, not nimodipine, protect neurons against anoxic damage in the rat hippocampal slice.

Authors:  I S Kass; J E Cottrell; G Chambers
Journal:  Anesthesiology       Date:  1988-11       Impact factor: 7.892

7.  Modulation of cytokines and myocardial lesions by vitamin E and chloroquine in a Mg-deficient rat model.

Authors:  W B Weglicki; R E Stafford; A M Freedman; M M Cassidy; T M Phillips
Journal:  Am J Physiol       Date:  1993-03

8.  Suppression of neutrophil and endothelial activation by substance P receptor blockade in the Mg-deficient rat.

Authors:  I Tong Mak; Jay H Kramer; William B Weglicki
Journal:  Magnes Res       Date:  2003-06       Impact factor: 1.115

9.  Azidothymidine promotes free radical generation by activated macrophages and hydrogen peroxide-iron-mediated oxidation in a cell-free system.

Authors:  Andrei M Komarov; Jonathon M Hall; William B Weglicki
Journal:  Biochim Biophys Acta       Date:  2004-04-05

10.  Substance P and neurotensin: discovery, isolation, chemical characterization and physiological studies.

Authors:  S E Leeman
Journal:  J Exp Biol       Date:  1980-12       Impact factor: 3.312

View more
  11 in total

1.  Substance P receptor blocker, aprepitant, inhibited cutaneous and other neurogenic inflammation side effects of the EGFR1-TKI, erlotinib.

Authors:  Joanna J Chmielinska; Jay H Kramer; I-Tong Mak; Christopher F Spurney; William B Weglicki
Journal:  Mol Cell Biochem       Date:  2019-12-18       Impact factor: 3.396

2.  Loss of neutral endopeptidase activity contributes to neutrophil activation and cardiac dysfunction during chronic hypomagnesemia: Protection by substance P receptor blockade.

Authors:  I Tong Mak; Joanna J Chmielinska; Jay H Kramer; Christopher F Spurney; William B Weglicki
Journal:  Exp Clin Cardiol       Date:  2011

3.  Hypomagnesemia and atherogenic dyslipidemia in chronic kidney disease: surrogate markers for increased cardiovascular risk.

Authors:  Ritwik Dey; Medha Rajappa; Sreejith Parameswaran; G Revathy
Journal:  Clin Exp Nephrol       Date:  2015-02-20       Impact factor: 2.801

Review 4.  Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia.

Authors:  Jay H Kramer; Christopher Spurney; Micaela Iantorno; Constantine Tziros; I-Tong Mak; M Isabel Tejero-Taldo; Joanna J Chmielinska; Andrei M Komarov; William B Weglicki
Journal:  Am J Med Sci       Date:  2009-07       Impact factor: 2.378

Review 5.  The NO/ONOO-cycle as the central cause of heart failure.

Authors:  Martin L Pall
Journal:  Int J Mol Sci       Date:  2013-11-13       Impact factor: 5.923

6.  Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance.

Authors:  Prema Robinson; Moses Kasembeli; Uddalak Bharadwaj; Nikita Engineer; Kris T Eckols; David J Tweardy
Journal:  Biomed Res Int       Date:  2016-02-11       Impact factor: 3.411

Review 7.  Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials.

Authors:  Juan R Muñoz-Castañeda; María V Pendón-Ruiz de Mier; Mariano Rodríguez; María E Rodríguez-Ortiz
Journal:  Int J Mol Sci       Date:  2018-02-27       Impact factor: 5.923

8.  Combination ART-Induced Oxidative/Nitrosative Stress, Neurogenic Inflammation and Cardiac Dysfunction in HIV-1 Transgenic (Tg) Rats: Protection by Mg.

Authors:  I Tong Mak; Joanna J Chmielinska; Christopher F Spurney; William B Weglicki; Jay H Kramer
Journal:  Int J Mol Sci       Date:  2018-08-15       Impact factor: 5.923

Review 9.  The Role of Disturbed Mg Homeostasis in Chronic Kidney Disease Comorbidities.

Authors:  Cristian Rodelo-Haad; M Victoria Pendón-Ruiz de Mier; Juan Miguel Díaz-Tocados; Alejandro Martin-Malo; Rafael Santamaria; Juan Rafael Muñoz-Castañeda; Mariano Rodríguez
Journal:  Front Cell Dev Biol       Date:  2020-11-12

10.  Circulating Glutamate and Taurine Levels Are Associated with the Generation of Reactive Oxygen Species in Paroxysmal Atrial Fibrillation.

Authors:  Shintaro Takano; Kousuke Fujibayashi; Nakaba Fujioka; Ei-ichi Ueno; Minoru Wakasa; Yasuyuki Kawai; Kouji Kajinami
Journal:  Dis Markers       Date:  2016-01-06       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.